RNA Therapeutics. The Evolving Landscape of RNA Therapeutics.
Giangrande, Paloma H. Redakcja, de Franciscis, Vittorio Redakcja, Rossi, John J. Redakcja
Year of publication: 2022
Kwasy nukleinowe
available:
1 from 1
Author
Giangrande, Paloma H. Redakcja
de Franciscis, Vittorio Redakcja
Rossi, John J. Redakcja
Title
RNA Therapeutics. The Evolving Landscape of RNA Therapeutics.
ISBN
978-0-12-821595-1
Place of publication
New York
Publishing house
Elsevier Science Publishing Co Inc
Year of publication
2022
Volume
472 stron
Dimensions
23,5 cm
Object passwords
Kwasy nukleinowe
Summary
RNA Therapeutics: The Evolving Landscape of RNA Therapeutics provides a comprehensive overview of RNA therapeutic modalities, from bench-to-bedside, with an emphasis on the increasingly impactful areas of gene therapy, oligonucleotide therapeutics, gene editing and delivery. International leaders in the field examine RNA-based therapeutics tools that have been developed to-date to modulate cellular processes such as transcription, translation and protein function. Approved RNA-based therapies and lessons learned from failed therapies are discussed in-depth, as are evolving advances in RNA biochemical analysis, and similar advances that are enabling clinical application of RNA-based therapies. Later sections discuss delivery technologies, remaining hurdles in research and translation, the therapy development process from the lab to the clinic, and novel RNA-based therapies currently in development.
020
%a 9780128215951
245
%a RNA Therapeutics.
%b The Evolving Landscape of RNA Therapeutics.
260
%a New York
%b Elsevier Science Publishing Co Inc
%c 2022
300
%a 472 stron
%c 23,5 cm
520
%a RNA Therapeutics: The Evolving Landscape of RNA Therapeutics provides a comprehensive overview of RNA therapeutic modalities, from bench-to-bedside, with an emphasis on the increasingly impactful areas of gene therapy, oligonucleotide therapeutics, gene editing and delivery. International leaders in the field examine RNA-based therapeutics tools that have been developed to-date to modulate cellular processes such as transcription, translation and protein function. Approved RNA-based therapies and lessons learned from failed therapies are discussed in-depth, as are evolving advances in RNA biochemical analysis, and similar advances that are enabling clinical application of RNA-based therapies. Later sections discuss delivery technologies, remaining hurdles in research and translation, the therapy development process from the lab to the clinic, and novel RNA-based therapies currently in development.
650
%a Kwasy nukleinowe
700
%a Giangrande, Paloma H.
%e Redakcja
700
%a de Franciscis, Vittorio
%e Redakcja
700
%a Rossi, John J.
%e Redakcja
920
%a 978-0-12-821595-1
Available items
1.
Accession: 4476
Signature: 4476/11
Signature: 4476/11
Status: Checked in